ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

ResMed Inc (RMD) reports robust revenue growth and increased profitability, while navigating freight cost pressures and ...

Medical equipment maker ResMed reported first-quarter revenue and earnings growth, driven by increased demand in the ...

Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27%Operating cash flow of $326 millionNote: A webcast of ...

ResMed revealed that its new strategy is expected to see it help more than 500 million people worldwide achieve their full health potential in 2030. The company's chair and CEO, Mick Farrell ...

Gift 5 articles to anyone you choose each month when you subscribe. Sleep devices company ResMed has told investors it can deliver high single-digit revenue growth over the next five years ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

On Friday, ResMed (NYSE:RMD) shares received a reiterated ... Similarly, across product categories, devices and masks/accessories saw robust growth. Notably, the company's gross margin improved ...

As a result, its EPS of $2.08 surpassed the consensus estimate by 2.5%, For the full year, analysts project RMD to report an EPS of $9.02, up 16.8% from $7.72 in fiscal 2023. ResMed's strong ...